Optimizing outcomes in myelofibrosis: The era of combination strategies

Monday, October 19, 2026

20:00–21:00 CEST

Register now Add to Calendar

This independent educational activity is supported by Novartis. All content is developed by the faculty in collaboration with SES. Funders are allowed no influence. 

Agenda

CME accreditation badge

This program has been accredited for 1 hour of CME credit.

Learning objectives 

Following the symposium, learners will be able to:  

  • Identify the limitations of current approved therapies and remaining unmet clinical needs in the treatment of myelofibrosis. 
  • Explain the biological mechanisms underlying myelofibrosis and the rationale for multi-pathway targeting.  
  • Evaluate the efficacy, safety, and potential clinical roles of current and emerging JAKi-based combination approaches for patients with myelofibrosis.  
  • Assess emerging evidence and clinical considerations that may inform the future optimization of combination treatment strategies in myelofibrosis.   

Our speakers

Aaron Gerds

Aaron Gerds

Cleveland Clinic Taussig Cancer Institute
Cleveland, US
Jean-Jacques Kiladjian

Jean-Jacques Kiladjian

Université Paris Cité and Hôpital Saint-Louis
Paris, FR
John Mascarenhas

John Mascarenhas

Icahn School of Medicine at Mount Sinai
New York, US

About SES

Delivering streamlined independent medical education to enhance clinical practice. SES hubs allow time-stretched healthcare professionals to easily access curated scientific, medical, and clinical information that expedites their learning and empowers their treatment decisions. Informed by patients, curated by world leaders, and endorsed by expert societies, our hubs support healthcare professionals worldwide with up-to-date, accessible, and impactful educational content. 

Visit SES

About the MPN Hub

The MPN Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in MPN. Our aim is to enhance knowledge in MPN, through the multichannel dissemination of global advances related to their classification, diagnosis, treatment, and management. 

The MPN Hub shares new data, evidence-based articles, therapy approvals, expert opinions, and international congress coverage with treatment teams and researchers around the world. 

Visit the MPN Hub

Registration form

Registration is free.

By registering for this symposium, you confirm that you are not an HCP practicing in the UK or USA. This content is intended solely for HCPs practicing outside these jurisdictions.

Required fields

Thank you!

You have successfully registered for the webinar.

Please check your email for further information on how to attend.

Add to Calendar